Innovative Partnership to Protect 60 Million People from Malaria

Introduction

A groundbreaking partnership has emerged as SC Johnson, the U.S. State Department, and the Global Fund join forces to combat malaria. This innovative collaboration, announced on May 13, 2026, aims to provide assistance to over 60 million people in Sub-Saharan Africa within three years. The project centers around SC Johnson Guardian™, a pioneering mosquito repellent product designed to reduce the transmission of malaria and other insect-borne diseases.

The Impact of Malaria

Malaria continues to be a significant global health issue, particularly in Sub-Saharan Africa, where it claims the lives of over 600,000 individuals annually, with a high percentage being children under five years of age. This staggering statistic underpins the urgency of introducing new preventive measures to avert further fatalities. Without swift action and the deployment of new tools, the burden of malaria is projected to rise.

Overview of the Initiative

The three-year agreement prioritizes the expansion of access to SC Johnson Guardian™, an innovative and low-cost product designed to provide long-lasting protection against malaria. Fisk Johnson, Chairman, and CEO of SC Johnson, emphasized that this initiative stems from over a decade of work to develop affordable repellent solutions for the world's most vulnerable populations.

Guardian is a non-electric repellent that can effectively safeguard users against insect bites for up to one year. With manufacturing facilities in Nairobi, Kenya, equipped to produce up to 20 million units per year, SC Johnson is well-positioned to address the urgent need for effective malaria prevention tools.

Sustainability and Local Impact

Central to the program is the focus on sustainable production practices in Sub-Saharan Africa, aligning with the Global Fund's mission to enhance equitable access to lifesaving malaria prevention tools. By utilizing American innovations alongside the Global Fund's extensive supply chains, the initiative aims to establish a local manufacturing presence while creating thousands of jobs in research and production.

Partnerships Driving Innovation

Jeremy P. Lewin from the U.S. State Department highlighted the role of American leadership in advancing global health initiatives. He spoke about Secretary Rubio’s conviction in leveraging new technologies developed in the U.S. to strategically combat global health crises, such as malaria. Peter Sands, Executive Director of the Global Fund, echoed this sentiment, emphasizing how innovative partnerships are crucial in staying ahead of malaria and saving lives.

Important Figures and Investments

SC Johnson has invested over $120 million into the development, testing, and production of Guardian as part of their commitment to public health. The partnership aims to improve malaria prevention and bolster efforts to eradicate the disease in high-risk areas.

Conclusion

In conclusion, the collaboration between SC Johnson, the U.S. State Department, and the Global Fund represents a significant step forward in the fight against malaria. By leveraging innovative technology and a commitment to local manufacturing, this initiative is poised to make a lasting impact on the health and lives of millions in Sub-Saharan Africa, underscoring the critical role of effective partnerships in global health initiatives.
For more information on SC Johnson's efforts to prevent malaria and other insect-borne diseases, you can visit scjohnson.com.

For press inquiries:
SC Johnson Global Corporate Communication
Email: [email protected]